1. Home
  2. SLRC vs FNA Comparison

SLRC vs FNA Comparison

Compare SLRC & FNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SLRC
  • FNA
  • Stock Information
  • Founded
  • SLRC 2007
  • FNA 2010
  • Country
  • SLRC United States
  • FNA United States
  • Employees
  • SLRC N/A
  • FNA N/A
  • Industry
  • SLRC Finance/Investors Services
  • FNA Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • Sector
  • SLRC Finance
  • FNA Health Care
  • Exchange
  • SLRC Nasdaq
  • FNA Nasdaq
  • Market Cap
  • SLRC 895.2M
  • FNA 910.9M
  • IPO Year
  • SLRC 2010
  • FNA 2021
  • Fundamental
  • Price
  • SLRC $16.89
  • FNA $13.03
  • Analyst Decision
  • SLRC Hold
  • FNA Buy
  • Analyst Count
  • SLRC 5
  • FNA 7
  • Target Price
  • SLRC $15.85
  • FNA $15.20
  • AVG Volume (30 Days)
  • SLRC 217.9K
  • FNA 2.0M
  • Earning Date
  • SLRC 05-07-2025
  • FNA 03-06-2025
  • Dividend Yield
  • SLRC 9.71%
  • FNA N/A
  • EPS Growth
  • SLRC 25.36
  • FNA N/A
  • EPS
  • SLRC 1.76
  • FNA N/A
  • Revenue
  • SLRC $232,431,000.00
  • FNA $256,182,000.00
  • Revenue This Year
  • SLRC N/A
  • FNA $14.88
  • Revenue Next Year
  • SLRC N/A
  • FNA $13.92
  • P/E Ratio
  • SLRC $9.62
  • FNA N/A
  • Revenue Growth
  • SLRC 1.36
  • FNA 18.39
  • 52 Week Low
  • SLRC $14.41
  • FNA $4.65
  • 52 Week High
  • SLRC $17.94
  • FNA $13.13
  • Technical
  • Relative Strength Index (RSI)
  • SLRC 40.04
  • FNA 67.34
  • Support Level
  • SLRC $17.14
  • FNA $12.98
  • Resistance Level
  • SLRC $17.94
  • FNA $13.08
  • Average True Range (ATR)
  • SLRC 0.38
  • FNA 0.05
  • MACD
  • SLRC -0.09
  • FNA -0.07
  • Stochastic Oscillator
  • SLRC 9.48
  • FNA 60.71

About SLRC SLR Investment Corp.

SLR Investment Corp is a closed-end externally managed, non-diversified management investment company that has elected to be treated as a business development company. It provides U.S. middle market businesses and intermediaries with bespoke debt financing solutions to fund working capital, acquisition, refinancing and growth capital requirements. It invests majorly in leveraged middle-market companies in the form of senior secured loans, financing leases and to a lesser extent, unsecured loans and equity securities.

About FNA Paragon 28 Inc.

Paragon 28 Inc is a medical devices company that develops, distributes, and sells medical devices in the foot and ankle segment of the orthopedic implant marketplace. Its products include plates and plating systems, screws, staples, and nails aimed to address all major foot and ankle procedures including ankle, Charcot, fracture fixation, hallux valgus, hammertoe, and flat foot. The company's suite of surgical solutions comprises nearly 80 product systems to help fit the specific needs of each patient and procedure. Geographically the company generates the majority of its revenue from the United States.

Share on Social Networks: